JUN 09, 2020 10:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Impacting Patient Outcomes With Rapid Positive Blood Culture ID Utilizing MALDI Mass Spectrometry

Sponsored by: Bruker Daltonics
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Director of Infectious Disease Testing and Immunology, CompuNet Dayton OH
    Biography
      Ike Northern has been employed at Compunet Clinical Lab in Dayton, Ohio since 1989 and serves as the Director of Infectious Disease Testing. He has also held the position of Microbiology System Specialist for Premier Health System for the past 4 years. He has a BS in Medical Technology from University of Cincinnati and a MS in Microbiology & Immunology from Wright State University. Ike has been active in training Clinical Lab Science students both in the classroom and the lab environment. He has also been a member of the American Society for Microbiology and the South Central Association for Clinical Microbiology, where he has held several board positions. His duties include oversite of the Microbiology, Serology, and Molecular departments at CompuNet. In addition, he is charged with standardization of microbiology testing across the Premier Health System in Dayton, Ohio and serving on the Antibiotic Stewardship and Infection Control Committees.

    Abstract
    DATE:   June 9, 2020
    TIME:   10:00am PT, 1:00pm ET
     
    What is sepsis and why is it important to act fast when performing diagnostic tests in the clinical laboratory? During the webinar we will learn about the importance of having a rapid method for identification (ID) of microorganisms directly from positive blood cultures. Some of the rapid methods available in the market today, including the MBT Sepsityper® solution*, will be discussed in detail. The MBT Sepsityper® solution utilizes the MALDI Biotyper® MALDI-TOF mass spectrometer to provide a rapid and highly accurate ID directly from positive blood cultures. Details such as the validation, implementation, and performance of this application will be elaborated, and the impact will be illustrated by actual patient case studies. A question and answer session will be held at the end of the presentation.
     
    Learning Objectives:
    • Explain clinical presentation of sepsis and the importance of fast laboratory testing
    • Describe the importance of using rapid diagnostics when performing ID directly from positive blood cultures
    • Outline the validation and implementation of MBT Sepsityper® solution
    • Summarize the impact on patient outcomes when using a rapid ID method directly from positive blood cultures, such as the MBT Sepsityper® solution
    * CompuNet Clinical Laboratories have validated all described non-IVD methods, software, kits and workflows for in-house clinical use.
     
    FDA clearance for Bruker´s MBT Sepsityper® Kit US IVD is pending.
     

     

    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

     


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    Loading Comments...
    Show Resources
    Event Countdown
    • 0 Days
    • 0 Hours
    • 0 Minutes
    • 0 Seconds
    Attendees
    • See more